HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 8 Hours

×
10 articles summarized · Last updated: LATEST

Last updated: July 7, 2026, 5:30 AM ET

European Private Equity Activity

Apheon has acquired French frozen snack producer Alma, bringing together two manufacturers of premium frozen products and food components. The deal signals continued private equity appetite for the food sector, with Apheon eyeing further expansion into Germany, the UK, and the Benelux region. Separately, EQT is set to acquire Corza Medical’s biosurgery business, which specializes in rapid bleeding control and tissue sealing. This move aligns with EQT's strategy to invest in healthcare and life sciences assets. Meanwhile, Advent International has taken a 7% stake in Italian space and defense propulsion group Avio, aiming to support the company's expansion in solid rocket motor technology.

Tech & Healthcare Exits and Investments

Thoma Bravo has closed a merger combining FP&A and portfolio management software firm Hypergene with governance, risk, and compliance specialist Stratsys. This consolidation creates a broader software offering for clients in the Nordic region and Germany. In a notable exit, Summit Partners has sold Dreampath Diagnostics, a provider of pathology lab sample tracking systems serving over 500 labs globally, to Halma. On the funding front, Google is backing Proxima Fusion with a €411 million investment, supporting the company's efforts in fusion energy. Additionally, Hive has raised $15 million for its AI technology, which claims to reduce the hourly cost of running machines by 80%.

Venture Capital & Public Market Debuts

Novo Holdings, the investment manager for the Novo Nordisk Foundation's $36 billion portfolio, is increasing its focus on planetary health and considering allocations to private equity general partners. The firm is also expanding its presence in Asia. In a positive public market debut, IQM investors applauded the company's initial trading performance. These developments reflect ongoing investor interest in specialized technology and sustainable ventures, even as larger private equity firms explore new avenues for growth and capital deployment.